low dose Aspirin for improving fatigue of multiple sclerosis patients
Phase 4
Recruiting
- Conditions
- Multiple sclerosisNeurological - Multiple sclerosis
- Registration Number
- ACTRN12610000353099
- Lead Sponsor
- nabavi ,seyed masoud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
known cases of relapsing-remitting ,secondary progressive,primary progressive Multiple sclerosis
-ability to walk at least 100 meters without help
Exclusion Criteria
-co-existence of cardiac, respiratory, metabolic disease
-exacerbation of disease in the recent month
-consuming drugs affecting neurological system in 2 weeks before start point
-major depression
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fatigue impact scale[8 weeks following randomisation];depression(Beck 2 score)[8 weeks following randomisation]
- Secondary Outcome Measures
Name Time Method nil[nil]